The Monash Institute of Pharmaceutical Sciences (MIPS) is a dynamic, innovative and ambitious research institute, comprising over 400 scientists engaged in research in drug discovery, design, delivery and use. As part of the top ranked Pharmacy Faculty in the Asia Pacific, we collaborate with leading pharmaceutical partners and our discoveries have impact worldwide. Our therapeutic strengths lie in neuroscience and mental health, cardiovascular and metabolic health and global health. We are committed to research translation and have made major contributions to collaborative drug discovery programs that have progressed more than 30 novel drug candidates into clinical development.
Key Research Areas
- Discovery Biology
- Medicinal Chemistry
- Drug Delivery Disposition and Dynamics
- Centre for Medicine, use and Safety
Top 5 Research Centres
Our top 5 research centres include:
- ARC Training Centre for Cryo-Eöectron Microscopy of Membrane Proteins
- ARC Training Centre for Fragment Based Design
- Centre for Drug Candidate Optimisation
- Centre for Medicine, Use and Safety
Find current research projects and opportunities here.
Research Achievements
- #1 in the world for pharmacy and pharmacology (2022 QS World Rankings by subject)
- Excellence in Research for Australia 2018 - Top rating of 5 in all sectors (well above world standard)
- Pharmalliance with University of North Carolina at Chapel Hill, US and University College London, UK
Numbers
- 6 Research Centres
- 256 Research Students
- 282 Research Staff/Supervising academics
Funding
$ 40 million external research funding
